Vaccine News and Research

Latest Vaccine News and Research

Analysis supports phase 3 trials of Johnson & Johnson's COVID-19 vaccine

Researchers in the Netherlands, the United States, and Belgium have presented early-stage clinical trial results demonstrating the safety and efficacy of Johnson & Johnson's vaccine candidate for coronavirus disease 2019 (COVID-19).

17 Jan 2021

Study reveals possible SARS-CoV-2 escape mutant that may re-infect immune individuals

A recent study by US researchers shows how the 501Y.V2 variant of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), characterized by several mutations, is able to escape neutralization by present first-wave anti-SARS-CoV-2 antibodies and potentially re-infect COVID-19 convalescent individuals.

17 Jan 2021

Black Americans are getting vaccinated at lower rates than white Americans

Black Americans are receiving covid vaccinations at dramatically lower rates than white Americans in the first weeks of the chaotic rollout, according to a new KHN analysis.

17 Jan 2021

UW–Madison tool aids in equitable vaccine distribution

The demand for COVID-19 vaccines continues to outpace supply, forcing public health officials to decide who should be first in line for a shot, even among those in the same pool of eligible vaccine recipients.

16 Jan 2021

National consortium to study the effects of emerging SARS-CoV-2 mutations

A new national research project to study the effects of emerging mutations in SARS-CoV-2 will be launched with £2.5 million of funding from UK Research and Innovation.

15 Jan 2021

Biden terms vaccine rollout ‘a dismal failure’ as he unveils his pandemic response plan

In the past 24 hours, President-elect Joe Biden has delivered two speeches focused on the nation's covid response.

15 Jan 2021

Myelin‐specific T cells implicated in central nervous system disease in monkeys

Scientists have uncovered new clues implicating a type of herpes virus as the cause of a central nervous system disease in monkeys that's similar to multiple sclerosis in people.

15 Jan 2021

Many older adults lack patient portal access, which could affect COVID-19 vaccine scheduling

As the vaccination of older adults against COVID-19 begins across the country, new poll data suggests that many of them don't yet have access to the "patient portal" online systems that could make it much easier for them to schedule a vaccination appointment.

15 Jan 2021

CVS and Walgreens under fire for slow pace of vaccination in nursing homes

The effort to vaccinate some of the country's most vulnerable residents against covid-19 has been slowed by a federal program that sends retail pharmacists into nursing homes — accompanied by layers of bureaucracy and logistical snafus.

15 Jan 2021

Geography is destiny: Dentists’ access to Covid shots depends on where they live

Dr. Monte Junker, an Oregon dentist, is waiting for his turn to get vaccinated for Covid even though he considers himself a front-line health worker.

15 Jan 2021

5 reasons to wear a mask even after you’re vaccinated

As an emergency physician, Dr. Eugenia South was in the first group of people to receive a covid vaccine. She received her second dose last week — even before President-elect Joe Biden.

15 Jan 2021

Lab study reveals effective treatment for COVID-19

A new potential therapy for COVID-19 developed by researchers at Rush University Medical Center has shown success in preventing the disease's symptoms in mice.

14 Jan 2021

KHN’s ‘What the Health?’: On Capitol Hill, actions have consequences

The reverberations from the Jan. 6 storming of the U.S. Capitol by supporters of President Donald Trump continue.

14 Jan 2021

EGR1 protein acts as a master regulator of inflammation in macrophages, study suggests

Scientists at The Wistar Institute discovered that Early Growth Response 1 (EGR1), a protein that turns on and off specific genes during blood cell development, inhibits expression of pro-inflammatory genes in macrophages.

14 Jan 2021

MVA SARS-CoV-2 vaccine candidate shows strong immunogenicity in preclinical trials

A new study reports the preclinical testing of a recombinant MVA (rMVA) candidate vaccine against SARS-CoV-2, the agent that is causing the current COVID-19 pandemic.

14 Jan 2021

Could intranasal SARS-CoV-2 vaccines be a practical alternative to intramuscular shots?

The unchecked advance of COVID-19 has made it a top public health priority to produce a vaccine capable of inducing a safe and powerful protective response against its causative pathogen: SARS-CoV-2. An encouraging new study shows the immunogenicity, safety, and protective efficacy, of a Newcastle disease virus (NDV)-based intranasal vector vaccine in animal studies.

14 Jan 2021

Influenza drug enisamium a potential COVID-19 treatment

Researchers in Europe and the United States have demonstrated the potential of the influenza drug enisamium as a treatment for infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).

13 Jan 2021

Study identifies features of potent SARS-CoV-2 neutralizing antibodies

Researchers at Columbia University have provided important insights into features of viral binding and recognition within a class of potent neutralizing antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).

13 Jan 2021

Moderna to develop three new mRNA-based vaccines against HIV, influenza, and the Nipah virus

Morderna has announced plans to develop a range of new mRNA-based vaccines against other viruses, including the influenza virus, human immunodeficiency virus (HIV), and the Nipah virus.

13 Jan 2021

New N501 SARS-CoV-2 mutation may have been circulating in Italy since August 2020

A recent study shows that mutated SARS-CoV-2 strains with a substitution at position 501 might have circulated unnoticed even before the end of September 2020, when the rapid emergence of B.1.1.7 lineage (carrying the N501Y mutation) was initially reported.

13 Jan 2021

Vaccine News and Research

Latest Vaccine News and Research

Analysis supports phase 3 trials of Johnson & Johnson's COVID-19 vaccine

Study reveals possible SARS-CoV-2 escape mutant that may re-infect immune individuals

Black Americans are getting vaccinated at lower rates than white Americans

UW–Madison tool aids in equitable vaccine distribution

National consortium to study the effects of emerging SARS-CoV-2 mutations

Biden terms vaccine rollout ‘a dismal failure’ as he unveils his pandemic response plan

Myelin‐specific T cells implicated in central nervous system disease in monkeys

Many older adults lack patient portal access, which could affect COVID-19 vaccine scheduling

CVS and Walgreens under fire for slow pace of vaccination in nursing homes

Geography is destiny: Dentists’ access to Covid shots depends on where they live

5 reasons to wear a mask even after you’re vaccinated

Lab study reveals effective treatment for COVID-19

KHN’s ‘What the Health?’: On Capitol Hill, actions have consequences

EGR1 protein acts as a master regulator of inflammation in macrophages, study suggests

MVA SARS-CoV-2 vaccine candidate shows strong immunogenicity in preclinical trials

Could intranasal SARS-CoV-2 vaccines be a practical alternative to intramuscular shots?

Influenza drug enisamium a potential COVID-19 treatment

Study identifies features of potent SARS-CoV-2 neutralizing antibodies

Moderna to develop three new mRNA-based vaccines against HIV, influenza, and the Nipah virus

New N501 SARS-CoV-2 mutation may have been circulating in Italy since August 2020

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Todd Bauman and Chris Povich

Vaccine News and Research

Latest Vaccine News and Research

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Todd Bauman and Chris Povich

Newsletters you may be interested in